Every material Form 8-K Vogenx, Inc. has filed with the SEC since August 19, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Vogenx director Richard Gorman resigned from the Board and all its committees, effective October 12, 2026, as he joins the company as Chief Commercial Officer. The filing says his resignation was not the result of any disagreement with the company, and Vogenx will search for a new independent director.
Gorman resigned from the Board and its Audit, Compensation, and Nominating and Corporate Governance Committees, effective October 12, 2026; he had served on the Board since 2022
Gorman becomes Chief Commercial Officer effective October 12, 2026, leading commercial operations and corporate strategy, with initial responsibility for business development and licensing strategy
The filing states the resignation was not due to any disagreement on operations, policies or practices
Vogenx will conduct a search to identify a new independent director
Vogenx, Inc. appointed Ken Toombs, former Chief Executive Officer of PA Consulting, to its Board of Directors effective September 21, 2026, as an independent Class II director. He also chairs the Audit Committee and sits on the Compensation and Nominating and Corporate Governance committees, and Peter Pieraccini was named Compensation Committee chair in connection with the appointment.
Ken Toombs appointed Class II director on September 21, 2026, to serve until the 2028 annual meeting
Toombs named Chair of the Audit Committee and also serves on the Compensation and Nominating and Corporate Governance committees
Peter Pieraccini appointed Chair of the Compensation Committee, effective September 21, 2026
The filing contains no financial results, revenue or guidance
Vogenx, Inc. closed the full exercise of the underwriter's over-allotment option on August 19, 2026, selling 937,500 additional shares at $13.00 each. Including these shares, the initial public offering totals 7,187,500 shares and about $93.4 million in gross proceeds before underwriting discounts, commissions and offering expenses.
The IPO initially closed on August 13, 2026, with 6,250,000 shares sold at $13.00 per share for $81.25 million in gross proceeds.
The over-allotment closing on August 19, 2026 added about $12.19 million in gross proceeds.
Total shares sold in the offering rose to 7,187,500, with JonesTrading Institutional Services LLC as underwriter.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Vogenx, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →